Congratulations to our portfolio company Tanvas on being named a Cool Vendor in Gartner, Inc.'s report Cool Vendors...
Read more
Actuate Therapeutics, Inc. has raised an additional $6.5M in a Series B-3 financing round led by Bios Partners with...
Read more
GuRu, a millimeter-wave (mmWave) technology company, has raised $15 million in Series A funding backed by Kairos Ventures and...
Read more
Congratulations to MixComm for securing $8.6M in Series B funding. Led by Kairos Ventures, these funds will be used...
Read more
Congratulations to Provivi for completing an $85 million Series C financing! Proceeds from the Series C financing will support...
Read more
The National Institutes of Health (NIH) has awarded Delpor, Inc. a grant for the development of a Once-Yearly Naltrexone...
Read more
Congratulations to Linnaeus for receiving clearance from the FDA for the company's investigational new drug application (IND) for LNS8801...
Read more
We are delighted to announce that Linnaeus Therapeutics, Inc. has closed a $12 million series B financing led by...
Read more
Foldax, Inc. announced its first-in-human use of the Tria heart valve under its FDA Early Feasibility Study (EFS) for...
Read more
Kairos Ventures portfolio company, Tanvas, proudly welcomes Phillip LoPresti as Chief Executive Officer. Tanvas, the surface haptic pioneer positions...
Read more